ARCHIVES

ASCO Names Stratetic Planning Committee

This article is from The Cancer Letter archive.

Vol. 14 No. 37 | September 23, 1988

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

RFP: Intellectual Property.

March 31, 2000

NCI, NSF fund awards in nanotech training.

September 23, 2005

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001